Ker, James A.2016-09-022016-09-022016-08Ker, J 2016, 'Pharmaceutical drugs in the treatment of STEMI', The Specialist Forum, vol. 16, no. 7, pp. 20.2218-8282http://hdl.handle.net/2263/56589Our concept of ST-segment Elevated Myocardial Infarction (STEMI) refers to when coronary blood supply decreases abruptly after a thrombotic occlusion. The underlying mechanism leading to the thrombotic event is an unstable atherosclerotic plaque which ruptured (or cracked or eroded) exposing the content of the plaque to the blood initiating thrombogenesis.en© The Specialist ForumThrombotic occlusionUnstable atherosclerotic plaqueCoronary blood supplyST-segment Elevated Myocardial Infarction (STEMI)Article